Both Monoclonal and Polyclonal Immunoglobulin Contingents Mediate Complement Activation in Monoclonal Gammopathy Associated-C3 Glomerulopathy
Sophie Chauvet(Assistance Publique – Hôpitaux de Paris), Véronique Fremeaux-Bacchi(Inserm), Alexandre Karras(Délégation Paris 5), Moglie Le Quintrec(Centre de Recherche des Cordeliers), Lubka T. Roumenina(Université Paris Cité), Dominique Guerrot(Pediatric Nephrology of Alabama), Yahsou Delmas(Centre Hospitalier Universitaire de Bordeaux), Maria-Chiara Marinozzi(Inserm), Marie‐Agnès Dragon‐Durey(Centre de Recherche des Cordeliers), Frank Bridoux(Université de Poitiers), Pièrre Aucouturier(Sorbonne Université), Pierre Ronco(Inserm), David Ribes(Centre Hospitalier Universitaire de Toulouse), Noémie Jourde‐Chiche(Aix-Marseille Université)
Cited by 85
Related Papers
KDIGO 2021 Clinical Practice Guideline for the Management of Glomerular Diseases
|Kidney International|2021|2.5k
Complement System Part I – Molecular Mechanisms of Activation and Regulation
|Frontiers in Immunology|2015|1.5k
Definition of organ involvement and treatment response in immunoglobulin light chain amyloidosis (AL): A consensus opinion from the 10th International Symposium on Amyloid and Amyloidosis
|American Journal of Hematology|2005|1.4k
Executive summary of the KDIGO 2021 Guideline for the Management of Glomerular Diseases
|Kidney International|2021|809